Skip to main content
Log in

Giant Malignant Insulinoma

  • GI Image
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

The role of debulking resections in giant malignant insulinoma is still controversial. Here, we report the case of a 49-year-old patient woman with a giant malignant symptomatic insulinoma, who underwent debulking surgery, realizing a total pancreatectomy, splenectomy, partial gastrectomy and cholecystectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ielpo, B., et al., Giant pancreatic insulinoma. The bigger the worse? Report of two cases and literature review. Int J Surg Case Rep, 2013. 4(3): p. 265–8.

    Article  PubMed  Google Scholar 

  2. Hirshberg, B., et al., Malignant insulinoma: spectrum of unusual clinical features. Cancer, 2005. 104(2): p. 264–72.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Scharf M1, et al., Management of a metastasized high grade insulinoma (G3) with refractory hypoglycemia: case report and review of the literature. Pancreatology. 2014 Nov-Dec;14(6):542–5.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marcello Di Martino.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Di Martino, M., García Sanz, I., Delgado Valdueza, J. et al. Giant Malignant Insulinoma. J Gastrointest Surg 20, 1530–1531 (2016). https://doi.org/10.1007/s11605-016-3118-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-016-3118-y

Keywords

Navigation